tirzepatide for hashimoto's disease Zepbound From Eli Lilly and Company Tirzepatide Microdose | GoodGirlRx

For people with type 2 diabetes receiving concomitant insulin or sulfonylureas, there is a theoretical risk of hypoglycaemia based on class experience with GLP-1-based therapies

And pretty much everything that we talked about here And so now lets get to it, the interventions

We can choose the best GLP-1 medication for your anatomy, lifestyle, and goals

When weight drops rapidly, the body often breaks down muscle for energy

This is clinically relevant because in May 2022, tirzepatide was approved in the USA to treat type 2 diabetes (Syed 2022)

However, there are instances where discontinuing the medication leads to weight regain